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Much has been investigated about clinical immunosuppression, however, regardless of treatment regimen, the immunosuppressant drugs have adverse effects including nephrotoxicity 5 , cardiovascular effects 5 , diabetes mellitus 5 , cosmetic effects such as hirsutism, gum hyperplasia, alopecia 5 , and changes in the wound healing process 6 . Nephrotoxicity is a major clinical obstacle related to immunosuppression with calcineurin inhibitors and is often responsible for the discontinuation of treatment 5 . The histological features of nephrotoxicity induced by these drugs are severe interstitial fibrosis, usually in stripes, peritubular calcification, arteriolar hyalinosis and focal glomerulosclerosis, these changes may result in irreversible chronic renal failure in patients undergoing renal transplantation 5 .
The ischemic time of the transplanted kidney is also noteworthy among the risk factors for the development of NPC Tx, with studies showing that a longer period of ischemia results in release of cytokines, significantly higher vascular and glomerular changes associated with increased risk of chronic rejection 4 .
Injury induced by ischemia and reperfusion has been studied as a risk factor for the development of post-transplant renal dysfunction. Studies have shown that rats undergoing transplantation with longer time of ischemia-reperfusion showed significantly higher vascular and glomerular changes than animals submitted to transplantation with shorter time of ischemia-reperfusion 7 . Moreover, the authors observed that the release of cytokines that accompanies the recovery phase of ischemic injury can trigger the cascade of events that would lead to chronic rejection 7 .
In this context, there are few studies assessing the simultaneous effect of drug-induced nephrotoxicity and of ischemia and reperfusion on post-transplant renal dysfunction 8 . 
Statistical analysis
The serum levels of tacrolimus, creatinine and urea were analyzed separately, with calculation of mean, median and standard deviation of each group. To compare the levels of serum tacrolimus and urea, we used the Student's t-test. For the analysis of creatinine values, we applied the nonparametric Mann-Whitney test. Histological changes were analyzed using the histological score. For comparison between groups, the nonparametric MannWhitney test was used, with significance level of 95% (p <0.05).
Results
Three rats died during the operative procedure, thus were excluded from the study. All animals were kept under the same care during the experiment, and none had complications or died during the postoperative observation.
Biochemical and statistical analysis
Serum levels of tacrolimus were higher according to the administered dose; in SHAM and control groups we did not detect serum levels of this drug. There was significant difference (p<0.05) in serum tacrolimus of the group T3 compared to the other groups ( Figure 2A ). The groups T1 and T2 showed difference in serum levels of tacrolimus, but it was not statistically significant (p = 0.084). The groups MT1 and MT2 had serum levels of tacrolimus statistically similar to groups T1 and T2.
Serum levels of urea were significantly greater in groups that received drugs compared to SHAM and control groups, except for the group M1, which exhibited no significant difference in relation to SHAM (M1xSHAM: p=0.19) ( Figure 2B ). The group T3 demonstrated a significant increase of urea in comparison On the first day after surgery, the animals received intramuscular analgesics (dipyrone) and daily, each group received a different type of solution by gavage with suitable technique and appropriate size of the tube (Table 1) .
Biochemical and histological analysis
The animals were killed on day 14 of the experiment, under the same anesthesia protocol. Median thoracotomy was performed, followed by cardiac puncture with 25x8 mm needle for taking blood sample, and induction of cardiac arrest by The analysis and anatomopathological interpretation were performed using light microscopy. The following parameters with all other groups (p<0.05). The group receiving MMF alone showed a significantly lower rate of urea increase compared to all other groups using tacrolimus, except for the group MT2 (half the usual dose of tacrolimus) (MxMT2: p = 0.28 ).
The group in which MMF was used alone and those groups in which MMF was combined with tacrolimus showed serum levels of creatinine significantly higher when compared with all other groups, except for the group T3, to which a higher dose of tacrolimus was administered (p>0.05).
Histological and statistical analysis
There Regarding the presence of hyaline casts, a statistical difference was observed between the group T3 and all other groups (p=0.01); only the rats of this group showed these histological changes ( Figure 3B ). Creatinine measurements showed no statistically significant differences between the groups control, SHAM, T1
and T2 with each other ( Figure 2C ). However, when creatinine values of the group T3 were compared to those of groups control, SHAM, T1 and T2, these differences were statistically significant. In this study, we used doses of tacrolimus between 0.1 mg/kg and 10mg/kg in order to observe the effects of medication from a sub-dose until high doses. According to Shihab et al. 9 , in which these lesions
were not apparent after seven days, but only after 28 days. In the same way, Nielsen et al. 12 , in the study period of 14 days showed minimal variance in the scores of fibrosis, as previously described. The most remarkable histological findings in this study were related to hyaline casts and cytoplasmic vacuolation of proximal tubules, characteristic of early nephrotoxicity. The first findings were evident only at high doses of tacrolimus.
Cytoplasmic vacuolation was identified at higher scores in groups under high doses of tacrolimus and in the group in which MMF was used alone. The combination between MMF and tacrolimus at usual dose did not potentiate the vacuolation score, but, when combined with half the usual dose of tacrolimus, the score was On the other hand, high doses of tacrolimus significantly increased serum creatinine levels when compared with the control group and the SHAM group but lower doses did not cause significant changes.
These results may be due to the fact that only the group T3 (mean = 2.35; SD = ± 0.67) presented serum levels of tacrolimus near the therapeutic range of the drug (5-15 ng/ml) 14, 15 .
The reason for not having achieved therapeutic serum levels, even having been administered high doses of tacrolimus, seems to be related to the bioavailability of the drug. Oral administration of tacrolimus has low bioavailability 9 . Studies have found that subcutaneous administration may achieve serum levels of the therapeutic window for humans 9. Besides that, these studies evidenced a high clearance of tacrolimus and higher volume of distribution in rats (2.0L/hr/kg and 20.2L/kg, respectively) in comparison with the pharmacokinetics in humans (0.1L/hr/kg and 1L/Kg, respectively), suggesting the use of higher doses in rats to reach the same serum levels 9 .
In this study, groups using MMF or MMF combined with tacrolimus showed significantly higher serum creatinine compared with all other groups, except for the group T3, in which a higher dose of tacrolimus was used (p> 0.05). Such findings may result from a sub-dose of tacrolimus in the groups T1, T2, MT1 and MT2. As emphasized previously, only the group T3 presented serum levels of tacrolimus close to the therapeutic range of the drug. Another important issue is that the mean values of creatinine in groups M1, MT1 and MT2 were respectively 0.55, 0.59 and 0.58, which were within normal reference standards of creatinine in rats (0.6 ± 0.02mg/dl) 16 .
Conclusions
Histologically, the association of injury by ischemiareperfusion with the use of tacrolimus or mycophenolate-mofetil alone demonstrated a higher rate of renal changes typical of early nephrotoxicity. In laboratory, the combination of injury by ischemia-reperfusion with tacrolimus at higher doses proved to be nephrotoxic.
